Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges
The Difficulties of Cloning a CEO - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case - Bloomberg Law
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva is on the prowl and its investors are taking notice
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
13 Billionaire Phillip Frost Interview As Opko Health Inc Lists On Tel Aviv Stock Exchange Photos and Premium High Res Pictures - Getty Images
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. | Barron's
Teva Pharmaceuticals - Wikipedia
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva makes $82 per share offer for rival Mylan
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
Teva Picked as Bellwether Target in Generic Drug Price-Fix Case
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
